<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>96(22)</volume><submitter>Zhuo C</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Parkinson disease (PD) was considered as the 2nd most prevalent neurodegenerative disorder after Alzheimer disease, while depression is a prevailing nonmotor symptom of PD. Typically used antidepression medication includes tricyclic antidepressants (TCA), selective serotonin reuptake inhibitors (SSRI), serotonin and norepinephrine reuptake inhibitors (SNRI), monoamine-oxidase inhibitors (MAOI), and dopamine agonists (DA). Our study aimed at evaluating the efficacy of antidepressive medications for depression of PD.&lt;h4>Methods&lt;/h4>Web of Science, PubMed, Embase, and the Cochrane library were searched for related articles. Traditional meta-analysis and network meta-analysis (NMA) were performed with outcomes including depression score, UPDRS-II, UPDRS-III, and adverse effe</pubmed_abstract><journal>Medicine</journal><pagination>e6698</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5459691</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Efficacy of antidepressive medication for depression in Parkinson disease: a network meta-analysis.</pubmed_title><pmcid>PMC5459691</pmcid><pubmed_authors>Xue R</pubmed_authors><pubmed_authors>Ji F</pubmed_authors><pubmed_authors>Tian H</pubmed_authors><pubmed_authors>Luo L</pubmed_authors><pubmed_authors>Lin X</pubmed_authors><pubmed_authors>Jiang R</pubmed_authors><pubmed_authors>Tao R</pubmed_authors><pubmed_authors>Qu H</pubmed_authors><pubmed_authors>Zhuo C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Efficacy of antidepressive medication for depression in Parkinson disease: a network meta-analysis.</name><description>&lt;h4>Background&lt;/h4>Parkinson disease (PD) was considered as the 2nd most prevalent neurodegenerative disorder after Alzheimer disease, while depression is a prevailing nonmotor symptom of PD. Typically used antidepression medication includes tricyclic antidepressants (TCA), selective serotonin reuptake inhibitors (SSRI), serotonin and norepinephrine reuptake inhibitors (SNRI), monoamine-oxidase inhibitors (MAOI), and dopamine agonists (DA). Our study aimed at evaluating the efficacy of antidepressive medications for depression of PD.&lt;h4>Methods&lt;/h4>Web of Science, PubMed, Embase, and the Cochrane library were searched for related articles. Traditional meta-analysis and network meta-analysis (NMA) were performed with outcomes including depression score, UPDRS-II, UPDRS-III, and adverse effe</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Jun</publication><modification>2025-04-04T12:29:07.075Z</modification><creation>2019-03-27T02:46:51Z</creation></dates><accession>S-EPMC5459691</accession><cross_references><pubmed>28562526</pubmed><doi>10.1097/MD.0000000000006698</doi></cross_references></HashMap>